Genetically engineered share of new medicine launches

STO-REC-STAT05HZG5T2 National
41%

Germany · 2025

Genetically engineered share of new medicine launches in Germany stood at 41% in 2025 (VFA).

Original source
Publisher
VFA
Authority tier
T2 National
Locator
Herstellungsarten
Retrieved
17 Sep 2026
Status
Verified

What the source says

Weitere 41 Prozent der Medikamente werden gentechnisch hergestellt.

Verbatim extraction verified: The figure 41% is directly attested in the quoted passage (Herstellungsarten).

The figure above was extracted from this passage. If it does not match, the extraction is wrong and we want to know.

Cite this figure

Published under CC BY 4.0. Attribute the original publisher; the citations below do that for you and link to this permanent record.

APA
VFA. (2025). Neue Medikamente in Deutschland: Innovationsbilanz 2025. Retrieved September 17, 2026, from https://www.vfa.de/de/forschung-entwicklung/meilensteine-und-neueinfuehrungen/innovationsbilanz-2025. Via StatOrigin, https://statorigin.org/stat/stat_05HZG55CCY2YWAZFFKT8YKEZCZ
MLA
VFA. "Neue Medikamente in Deutschland: Innovationsbilanz 2025." 2025, https://www.vfa.de/de/forschung-entwicklung/meilensteine-und-neueinfuehrungen/innovationsbilanz-2025. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_05HZG55CCY2YWAZFFKT8YKEZCZ.
Chicago
VFA. "Neue Medikamente in Deutschland: Innovationsbilanz 2025." 2025. https://www.vfa.de/de/forschung-entwicklung/meilensteine-und-neueinfuehrungen/innovationsbilanz-2025. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_05HZG55CCY2YWAZFFKT8YKEZCZ.
BibTeX
@misc{vfa2025geneticallyykezcz, author = {{VFA}}, title = {Neue Medikamente in Deutschland: Innovationsbilanz 2025}, year = {2025}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_05HZG55CCY2YWAZFFKT8YKEZCZ}, note = {Original source: https://www.vfa.de/de/forschung-entwicklung/meilensteine-und-neueinfuehrungen/innovationsbilanz-2025. Accessed September 17, 2026.} }

Provenance and verification

Everything needed to check this number yourself, without taking our word for it.

Chain of Custody · Verification Audit
Record: STO-REC-STAT05HZG5 T2 National

Primary Source

Publisher
VFA · homepage ↗
Authority tier
Tier 2 · National Official
Report
Neue Medikamente in Deutschland: Innovationsbilanz 2025
Type
Press release
Published
Locator
Herstellungsarten
Retrieved
17 September 2026
Link status
Reachable (HTTP 200)
Report licence
See source

Verification & Integrity

Audit status
Verified
Review protocol
Editorial review
Checked on
17 September 2026
Last revision
17 September 2026
Archival URI
/stat/stat_05HZG55CCY2YWAZFFKT8YKEZCZ